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X-ray crystallography reveals stringent conservation of protein
fold after removal of the only disulfide bridge from a stabilized
immunoglobulin variable domain
Isabel Usón1, M Teresa Bes1,2, George M Sheldrick1, Thomas R Schneider3,*,
Thomas Hartsch2 and Hans-Joachim Fritz2
Background: Immunoglobulin domains owe a crucial fraction of their
conformational stability to an invariant central disulfide bridge, the closure of
which requires oxidation. Under the reducing conditions prevailing in cell
cytoplasm, accumulation of soluble immunoglobulin is prohibited by its inability
to acquire and maintain the native conformation. Previously, we have shown that
disulfide-free immunoglobulins can be produced in Escherichia coli and purified
from cytoplasmic extracts.
Results: Immunoglobulin REIv is the variable domain of a human κ light chain.
The disulfide-free variant REIv-C23V/Y32H was crystallized and its structure
analyzed by X-ray crystallography (2.8 Å resolution). The conformation of the
variant is nearly identical to that of the wild-type protein and the
conformationally stabilized variant REIv-T39K. This constitutes the first crystal
structure of an immunoglobulin fragment without a disulfide bridge. The lack of
the disulfide bridge produces no obvious local change in structure (compared
with the wild type), whereas the Y32H mutation allows the formation of an
additional hydrogen bond. There is a further change in the structure that is seen
in the dimer in which Tyr49 has flipped out of the dimer interface in the mutant.
Conclusions: Immunoglobulin derivatives without a central disulfide bridge but
with stringently conserved wild-type conformation can be constructed in a
practical two-step approach. First, the protein is endowed with additional
folding stability by the introduction of one or more stabilizing amino acid
exchanges; second, the disulfide bridge is destroyed by substitution of one of
the two invariant cysteines. Such derivatives can be accumulated in soluble
form in the cytoplasmic compartment of the E. coli cell. Higher protein yields
and evolutionary refinement of catalytic antibodies by genetic complementation
are among the possible advantages.
Introduction
Mammals are able to mount a humoral immune response
to virtually any molecular shape. As a result of the
response, high-affinity antibodies directed against an
intruding antigen are produced and accumulate in the
serum by mechanisms that are now known in general
outline. In the course of individual development, a basal
repertoire of antibodies with different antigen-binding
selectivities is created by somatic genetic processes, start-
ing from a rather limited set of genetic information
present in the germline. Contact with a specific antigen
identifies good binders within this repertoire and triggers
their clonal amplification and structural refinement by
Darwinian selection. The structural basis of antigen
binding diversity is provided by sequence variation
within a set of protein surface loops, grafted onto an
invariant scaffold.
It has been realized that the generation of high-affinity
antibodies by the immune system constitutes a natural
model case of protein engineering and it is not surprising,
therefore, that antibodies have become a favorite starting
structure for the development of proteins with new and
predetermined properties, including chemical catalysis
[1]. Antibody engineering is not without pitfalls, however.
Members of the immunoglobulin superfamily of proteins
are made up of multiple modules of conserved folding
topology. These immunoglobulin domains are typically
∼100–120 amino acid residues long with the polypeptide
chain folded into an antiparallel β-sandwich structure.
The two sheets of the sandwich are held together by sec-
ondary forces and, critically, by an invariant disulfide
bridge buried in the hydrophobic interior of the domain
(e.g. Figure 1) [2]. If Escherichia coli is used as the produc-
tion host in antibody engineering projects, the reducing
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environment provided by the cytoplasm does not permit
closure of this disulfide bridge; secretion of the protein
into the periplasmic cell compartment is therefore
required [3–5], which imposes constraints on protein yield
and on the nature of catalytic functions that can be
selected for by genetic complementation.
Previously [6,7], we had shown that amino acid exchanges
can be made in the sequence of REIv (the variable
domain of a human κ light chain) that furnish the protein
with sufficient additional folding stability to make
removal of the central disulfide bridge without concomi-
tant collapse of the ordered fold feasible. The β-lacta-
mase/REIv-C23V/Y32H fusion protein from which the
free immunoglobulin domain is obtained can be accumu-
lated in the periplasmic or the cytoplasmic compartment
of the producing E. coli cells, depending on the presence
or absence of the secretion leader sequence in the N-ter-
minal β-lactamase moiety [6]. The disulfide bridge con-
tributes about 18 kJ mol–1 of folding stability to the total
∼25 kJ mol–1 of wild-type REIv [7]. Various low-resolu-
tion criteria such as CD spectra were shown not to be in
conflict with the assumption that REIv-C23V/Y32H has a
typical native immunoglobulin fold [6]. If, however,
disulfide-free immunoglobulin fragments are to be used
in antibody engineering as general structural scaffolds
(i.e. as recipients of loop transplants), it is essential to
know that their three-dimensional structure matches in
detail that of their natural counterparts (or deviates from
it in a controlled fashion that can be accommodated in
protein engineering schemes). With the present study,
we address this issue by X-ray crystal structure analysis of
REIv-C23V/Y32H.
Results and discussion
Effect of the mutations
As a result of the limited stability of the C23V/Y32H
mutant and the very long time required for crystal
growth, which made it difficult to grow large crystals,
together with the crystal decay during data collection, the
best resolution we could obtain for the X-ray data was
2.8 Å, despite the use of synchrotron radiation. The struc-
ture was determined by molecular replacement [8] using
as search models both the wild type [9] and the single
mutant T39K [7], both of which contain the disulfide
bond, with essentially identical results. Figure 2a shows
the electron density in the ex-disulfide region using
phases calculated from the unrefined molecular replace-
ment solution, with the search model superimposed;
removing the disulfide bond has produced a small dis-
placement of the chains away from one another, but other-
wise has had remarkably little effect. In view of the
possibility that model bias would lead to a structure too
close to the search model, the refinement was performed
separately for the two different models, using two differ-
ent programs [10,11], free R validation [12] and a variety
of protocols including simulated annealing [11]; the
results were very similar, differing primarily in the confor-
mations of poorly defined hydrophilic sidechains and the
three residues at the N terminus. Data collection and
refinement parameters are summarized in Table 1.
Replacement of Tyr32 by a histidine allows the formation
of an additional hydrogen bond between Nδ1 of His32 and
Oε1 of Glu50, as shown in Figure 2b,c; the electron density
shown in this figure also confirms that we were successful
in overcoming model bias. The replacement of tyrosine by
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Figure 1
Stereoview of a Cα trace of the wild-type REIv
monomer [9], showing the buried invariant
disulfide bridge. Drawn with SHELXTL [25].
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histidine also allows Oε1 of Glu50 to approach closer to Oη
of Tyr91, possibly because of the smaller steric require-
ment of histidine rather than tyrosine, strengthening the
Oη-H⋅⋅⋅Oε1 hydrogen bond. These interactions could
account for the additional 4.6 kJ mol–1 folding stability
observed for REIv-Y32H as compared to wild-type REIv
[7]. Residue 32 lies within the CDR1 region of the variable
domain, which precludes its general use as a target in
domain stabilization. A general approach, therefore, has to
be based on stabilization via exchange of framework
residues; sequence statistics of the entire immunoglobulin
family can provide a guiding rationale for this [13,14].
Overall conformation
Variable domains of immunoglobulin light chains often
form dimers, both in solution [7,15] and in the crystal
[9,16]. Dimerization in solution has been demonstrated
experimentally for REIv-Y32H; its association constant is
increased by a factor of about 10 relative to wild-type
REIv [7,15]. In the crystal, the asymmetric unit contains a
monomer and the dimer is formed through the action of a
crystallographic twofold axis. In the wild type and in the
T39K mutant, the dimer constitutes the crystallographic
asymmetric unit and a noncrystallographic twofold axis
relates the monomers. Least-squares superposition of the
monomer Cα atoms of the C23V/Y32H mutant to the wild
type and to the T39K mutant gave root mean square devi-
ations (rmsds) of 0.51 Å and 0.49 Å, respectively; the
closeness of the fit may be seen in Figure 3.
At one end of the dimer interface an unexpected structural
reorganization is observed. The sidechain of Tyr49 has
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Figure 2
Sigma-A maps [14] of the electron density drawn with O [22]. (a) The
region of the C23V mutation, based on phases from the molecular
replacement solution using the wild-type model, which is also shown.
Removal of the disulfide bridge results in a small movement of the
previously bridged chains away from one another, but no major
conformational changes result. (b) The region of the Y32H mutation,
with phases from the molecular replacement model. (c) The region of
the Y32H mutation after least-squares refinement. The Y32H mutation
enables an additional hydrogen bond to form between Nδ1 of His32
and Oε1 of Glu50. The maps show that model bias is not serious,
despite the modest resolution (2.8 Å).
Table 1
Data collection and refinement parameters.
Data collection
Total number of observations 37,985
Number of unique reflections 3549
Average I/σ (overall/last shell)* 11.1/2.7
Rint (%) (overall/last shell)* 10.4/37.6
Completeness (%) (overall/last shell)* 97.0/97.8
Refinement
Number of protein/solvent atoms 840/17
Rfree (%)† 34.3 (41.52 on all data)
R (%) 22.8 (28.00 on all data)
Rmsds from idealized geometry
Bond lengths (Å) 0.004
Bond angles (°) 1.5
Improper angles (°) 1.3
Dihedral angles (°) 30.2
Mean B factor (Å2)
Mainchain atoms 18.5
Sidechain atoms 19.0
Solvent atoms 30.7
*Overall data ∞–2.8 Å, last shell 2.85–2.8 Å. †10% data between 10 Å
and 2.8 Å (276 reflections, F > 4σ). Rint = Σ | I – 〈 I 〉 | / Σ 〈 I 〉;
R = Σ | | Fo | – | Fc | | / Σ | Fo |, (2639 reflections, F > 4σ).
flipped out of the dimer interface region, allowing the two
monomers to approach closer to one another (Figure 4).
The resulting interactions probably contribute to the rela-
tive stability of this particular disulfide-free mutant,
although it is not clear which mutation (if either) is the
indirect cause of the change in the dimer interface. The
rmsds of least-squares superposition of the dimer Cα atoms
to the wild type and T39K mutant are 1.60 Å and 1.64 Å,
respectively. The dimer interface in the T39K mutant is
similar to that in the wild type (Cα rmsd 0.42 Å).
Implications for folding and design
The role of the disulfide bond in the stability and folding
pathway of immunoglubulin fragments has been the
subject of intensive discussion [3,5–7,17–19]. This crystal
structure shows unequivocally that the removal of the
buried invariant disulfide bridge has an almost negligible
effect on the overall conformation of a VL monomer,
although an indirect effect on the detailed structure of the
dimer interface cannot be excluded. In contrast to previ-
ous work [3], we conclude that the disulfide bond forma-
tion is not essential for the correct folding of the protein,
and that it is possible that it may take place at a relatively
late stage in the folding pathway. Provided that other
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Figure 4
Stereoviews of one end of the dimer interface
(viewed from the hypervariable loops) for
(a) the C23V/Y32H mutant and (b) the
wild-type REIv [9], viewed down the twofold
axis. It can be seen that the sidechain of Y49
has flipped out of the interface region in the
mutant, allowing the two monomer units to
approach one another more closely. The other
end of the dimer interface along the twofold
axis is similar in both structures. Drawn with
SHELXTL [25].
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(a)
(b)
Figure 3
Least-squares superposition of the C23V/Y32H monomer to one
monomer unit of the wild-type REIv, drawn with Molscript [24]. The
rmsd of the Cα atoms is 0.51 Å.
H32
E50
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mutations confer sufficient stability, there is no reason
why specially designed disulfide-free immunoglobulin
fragments should not be accumulated in the cytoplasmic
compartment of E. coli or similarly reducing cell compart-
ments of other organisms. This may become especially
important in attempts to employ genetic complementation
in the evolutionary refinement of catalytic antibodies.
Materials and methods
REI-C23V/Y32H was produced and purified as described previously
[6]. Single crystals were obtained by vapour diffusion at 4°C in hanging
drops (6 µl) from a protein solution containing 8 mg ml–1 in 50 mM
potassium phosphate buffer at pH 7, using 2 M ammonium sulphate in
100 mM sodium acetate buffer (pH 4.6) as a precipitant in a 1:1 ratio.
The crystals grew over a period of seven months to a maximum size of
0.35 × 0.02 × 0.02 mm3. The crystals are hexagonal, space group
P6122, with cell dimensions a = b = 52.8(1) Å, c = 158.2(3) Å. With
one monomer in the asymmetric unit, the Matthews coefficient [20] Vm
is 2.67 Å3 Da–1 corresponding to 54% solvent. Data to 2.8 Å resolution
were collected at EMBL, c/o DESY, Hamburg, Germany, on the BW7A
synchrotron beamline with an X-ray wavelength of 0.901 Å and an MAR
image plate scanner. Data processing and merging were performed
using the computer program suite HKL [21]. A total of 3549 unique data
were measured at 4°C from two crystals due to decay (Rint = 0.104).
The structure of the C23V/Y32H mutant was determined using the
molecular replacement method with the AMoRe program [8]. As
search models, both a monomer of the REI wild type [9] and of the
T39K mutant [7] were used. After the AMoRe rotation and translation
functions and rigid body refinement using data between 6 Å and 3.5 Å,
R values of about 34% and correlation coefficients of about 70% were
obtained with both search models. The model was then refined as a
rigid body with SHELXL-96 [10], followed by simulated annealing with
X-PLOR [11]. Sigma-A maps [22] were displayed using O [23] for manual
editing of the structure. Engh and Huber [24] geometric restraints and
very tight B-value restraints were employed in the final SHELXL-96 refine-
ment against all data. Hydrogen atoms were included in geometrically
calculated positions (i.e. without introducing further parameters in the
model) and the final model contains 17 water molecules. After refine-
ments with 10% of the data reserved for Rfree had been used to estab-
lish a refinement protocol [12], the refinement was repeated using all
data; the results were essentially identical, but the maps calculated
with the full data were appreciably better in terms of the connectivity of
the density. The atomic coordinates and structure factors for REIv-
C23V/Y32H have been deposited with the PDB (accession numbers
1AR2 and R1AR2SF, respectively). Figures were drawn with O [23],
Molscript [25] and programs written by Sheldrick [26].
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